ZYXI
I added some ZYXI here in the $2.00-2.10 range. here is what I like.
1) ZYXI had an impressive quarter where they earned a whopping .07, and based on guidance I would expect even better in q4. Keep in mind they handily beat guidance in q3 as well, so that is possible as well.
2) ZYXI growth is for several reasons (1) They are trying to fight the pain issue with the opioid crisis (2) A competitor left the sector, and that is part of the growth. (3) They finally have their debt paid off, to accomodate growth they now have the cash flow to use, which they weren't able to take advantage of this opportunity until just now.
3) Now ZYXI the concerns are is this time different, well that time A/R was going through the roof, that isn't happening this time. Two we are no longer worried about the debt. Three they are producing a ton of cash flow.
Conclusion: Yes ZYXI has warts from it's past but this stock has good cash flow, the debt is behind them, unlike the last time there were problems a/r is not spiking. They have beat guidance for the last couple of quarters, and I think the stock in the low 2's is worth the risk here. All is just my opinion, and I could always be wrong though.
